MediciNova, Inc. (MNOV)
1.78
+0.15
(+9.20%)
USD |
NASDAQ |
Oct 02, 16:00
1.80
+0.02
(+1.12%)
After-Hours: 20:00
MediciNova Net Income (Quarterly) : -2.314M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -2.314M |
| March 31, 2026 | -2.586M |
| December 31, 2025 | -2.802M |
| September 30, 2025 | -3.050M |
| June 30, 2025 | -3.281M |
| March 31, 2025 | -2.864M |
| December 31, 2024 | -2.815M |
| September 30, 2024 | -2.852M |
| June 30, 2024 | -2.628M |
| March 31, 2024 | -2.754M |
| December 31, 2023 | -2.059M |
| September 30, 2023 | -0.7231M |
| June 30, 2023 | -2.872M |
| March 31, 2023 | -2.918M |
| December 31, 2022 | -3.002M |
| September 30, 2022 | -3.652M |
| June 30, 2022 | -4.029M |
| March 31, 2022 | -3.386M |
| December 31, 2021 | -2.083M |
| September 30, 2021 | -3.579M |
| June 30, 2021 | -4.284M |
| March 31, 2021 | -0.1878M |
| December 31, 2020 | -2.985M |
| September 30, 2020 | -3.704M |
| June 30, 2020 | -4.451M |
| Date | Value |
|---|---|
| March 31, 2020 | -2.714M |
| December 31, 2019 | -1.984M |
| September 30, 2019 | -2.378M |
| June 30, 2019 | -3.882M |
| March 31, 2019 | -4.697M |
| December 31, 2018 | -0.2079M |
| September 30, 2018 | -6.78M |
| June 30, 2018 | -3.144M |
| March 31, 2018 | -4.543M |
| December 31, 2017 | -1.603M |
| September 30, 2017 | -3.755M |
| June 30, 2017 | -2.789M |
| March 31, 2017 | -3.016M |
| December 31, 2016 | -1.449M |
| September 30, 2016 | -2.836M |
| June 30, 2016 | -3.199M |
| March 31, 2016 | -3.382M |
| December 31, 2015 | -2.735M |
| September 30, 2015 | -1.608M |
| June 30, 2015 | -2.287M |
| March 31, 2015 | -2.215M |
| December 31, 2014 | -2.381M |
| September 30, 2014 | -2.340M |
| June 30, 2014 | -2.122M |
| March 31, 2014 | -2.352M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Ironwood Pharmaceuticals, Inc. | 51.29M |
| Viking Therapeutics, Inc. | -128.02M |
| IDEAYA Biosciences, Inc. | -112.45M |
| ACADIA Pharmaceuticals, Inc. | 31.50M |
| Alnylam Pharmaceuticals, Inc. | 164.49M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 0.4584M |
| Total Expenses (Quarterly) | 2.773M |
| EPS Diluted (Quarterly) | -0.047 |
| Enterprise Value | 62.31M |
| Gross Profit Margin (Quarterly) | 68.22% |
| Profit Margin (Quarterly) | -504.8% |
| Earnings Yield | -12.29% |
| Normalized Earnings Yield | -12.29 |